Effect of Diastolic Dysfunction on Dynamic Cardiac Monitors

NCT ID: NCT04177225

Last Updated: 2021-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-02-07

Study Completion Date

2021-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This investigator initiated, prospective, observational, single-center study is designed to assess whether dynamic monitors of cardiac function such as stroke volume variation (SVV) that have been shown to predict volume responsiveness differ in clinical utility between patients with and without diastolic dysfunction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This investigator initiated, prospective, observational, single-center study is designed to assess whether dynamic monitors of cardiac function, such as stroke volume variation (SVV), that have been shown to predict volume responsiveness differ in clinical utility between patients with and without diastolic dysfunction.

Specific Aims:

* Determine the threshold for the predictive response of SVV with respect to increasing cardiac output for patients with and without diastolic dysfunction.
* Compare the trans thoracic ultrasound assessment of left ventricular diastolic function before and after the induction of general anesthesia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Volume Variation Diastolic Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with normal diastolic function

Patients undergoing scheduled surgical procedures requiring general anesthesia and invasive arterial pressure and advanced cardiac function monitoring. A trans thoracic ultrasound examination of cardiac function will be performed before induction of general anesthesia . In the operating room, the anesthesia care team will place all of the standard intra-operative monitors and then induce general anesthesia. After induction, the ultrasound examination will be repeated and the planned additional intra-operative monitors will be placed. The arterial catheter will be attached to a FloTrac/EV1000 monitor that will be used to guide fluid management during the procedure. The sensitivity and specificity of SVV to predict the response of cardiac output to intravenous fluid administration will be assessed in this patient group distinguished by their normal left ventricular diastolic function.

Trans thoracic Ultrasound Examination

Intervention Type PROCEDURE

Ultrasound examination of cardiac function before and after induction of general anesthesia.

Intravenous fluid administration

Intervention Type OTHER

Intravenous fluids will be administered as a bolus in response to standard clinical indications

Patients with abnormal diastolic function

Patients undergoing scheduled surgical procedures requiring general anesthesia and invasive arterial pressure and advanced cardiac function monitoring. A trans thoracic ultrasound examination of cardiac function will be performed before induction of general anesthesia . In the operating room, the anesthesia care team will place all of the standard intra-operative monitors and then induce general anesthesia. After induction, the ultrasound examination will be repeated and the planned additional intra-operative monitors will be placed. The arterial catheter will be attached to a FloTrac/EV1000 monitor that will be used to guide fluid management during the procedure. The sensitivity and specificity of SVV to predict the response of cardiac output to intravenous fluid administration will be assessed in this patient group distinguished by their abnormal left ventricular diastolic function.

Trans thoracic Ultrasound Examination

Intervention Type PROCEDURE

Ultrasound examination of cardiac function before and after induction of general anesthesia.

Intravenous fluid administration

Intervention Type OTHER

Intravenous fluids will be administered as a bolus in response to standard clinical indications

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trans thoracic Ultrasound Examination

Ultrasound examination of cardiac function before and after induction of general anesthesia.

Intervention Type PROCEDURE

Intravenous fluid administration

Intravenous fluids will be administered as a bolus in response to standard clinical indications

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients Undergoing Elective surgical procedures where invasive arterial line pressure monitoring is a planned part of the intraoperative management
* Age greater than or equal to 18
* Procedures requiring general anesthesia and mechanical ventilation

Exclusion Criteria

* Adults unable to provide consent
* Atrial Fibrillation or other significant active arrhythmia
* Emergency Procedures
* Hemodynamic instability requiring vasopressor and/or inotropic infusions
* Presence of an intra-aortic balloon pump
* Open thoracic procedures
* Extremes of BMI less than 20 or greater than 40
* Pregnancy
* Prisoners
* Patient Refusal
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Davis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Neal Fleming, MD

Role: PRINCIPAL_INVESTIGATOR

University of California, Davis

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UC Davis Health System

Sacramento, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Desai S, Hamilton Z, McCloskey L, Badakhsh O, Li D, Fleming NW. The effect of propofol on the grading of diastolic function: a prospective observational study. BMC Anesthesiol. 2025 Jul 30;25(1):376. doi: 10.1186/s12871-025-03260-2.

Reference Type DERIVED
PMID: 40739534 (View on PubMed)

Abdallah AC, Song SH, Fleming NW. A retrospective study of the effects of a vasopressor bolus on systolic slope (dP/dt) and dynamic arterial elastance (Eadyn). BMC Anesthesiol. 2024 Jul 29;24(1):257. doi: 10.1186/s12871-024-02574-x.

Reference Type DERIVED
PMID: 39075354 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1380344

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.